中国畜牧兽医 ›› 2024, Vol. 51 ›› Issue (1): 255-267.doi: 10.16431/j.cnki.1671-7236.2024.01.026

• 预防兽医 • 上一篇    下一篇

3种去势疫苗的构建及稳定性研究

彭静娜, 刘丽娟, 吕志远, 于志蓉, 孙旭阳, 许学林, 荆焕松, 熊家军   

  1. 华中农业大学动物科学技术学院, 武汉 430070
  • 收稿日期:2023-06-21 出版日期:2024-01-05 发布日期:2023-12-27
  • 通讯作者: 熊家军 E-mail:xiongjiajun@mail.hzau.edu.cn
  • 作者简介:彭静娜,E-mail:1064160473@qq.com。
  • 基金资助:
    国家自然科学基金(31972533)

Construction and Stability Study of Three Castrated Vaccines

PENG Jingna, LIU Lijuan, LYU Zhiyuan, YU Zhirong, SUN Xuyang, XU Xuelin, JING Huansong, XIONG Jiajun   

  1. College of Animal Science and Technology, Huazhong Agricultural University, Wuhan 430070, China
  • Received:2023-06-21 Online:2024-01-05 Published:2023-12-27

摘要: 【目的】试验旨在构建不同种类的新型免疫去势DNA疫苗,分别为KISS1、神经激肽B (NKB)单表达基因疫苗和促性腺激素释放激素(GnRH)、KISS1和NKB 3个基因共表达的三表达基因疫苗,注射到动物体内后能激发免疫反应,产生相应的抗体,从而达到通过调控生殖轴来降低雄激素的目的。【方法】选取下丘脑-垂体-性腺轴(hypothalamic pituitary gonadal axis)上的GnRH及其上游调控基因KISS1和NKB作为靶标,并引入平衡致死系统代替抗生素筛选构建重组质粒,其中三表达重组质粒借助2A肽的自剪切功能使目的基因共表达。将重组质粒转染293T细胞后提取细胞RNA,验证其能否在机体内正常表达,随后将构建成功的质粒电转到减毒猪霍乱沙门菌(Salmonella Choleraesuis) C500感受态细胞中,获得重组活菌疫苗,构建的工程菌在体外连续传代50次,选取第0、2、5、10、20、30、40、50代的菌株进行稳定性研究。【结果】重组质粒pVAX-2A/KISS1-asd、pVAX-2A/S-NKB-asd和pVAX-S/GnRH-2A/S-NKB-2A/KISS1-asd酶切分别获得大小为498、1 146和2 622 bp的条带,与目的基因一致;测序结果与目的序列比对后显示大小、方向一致,目的基因的插入方向和序列完全正确。将上述重组质粒转染293T细胞后进行RT-PCR,获得大小分别为498、1 146、1 349 bp的目的条带,表明目的基因在真核细胞内能正常转录。上述重组质粒电转到减毒猪霍乱沙门菌C500感受态细胞后,提取质粒酶切后获得大小分别为498、1 146和2 622 bp的条带,测序结果与目的序列比对后显示大小、方向一致,表明重组质粒成功导入减毒猪霍乱沙门菌C500中。每2 h检测的工程菌和减毒猪霍乱沙门菌C500对照菌D600 nm值接近,差异不显著;生长曲线检测结果显示,工程菌在体外连续传代50次的过程中,工程菌和减毒猪霍乱沙门菌对照菌C500对数生长期均在0~10 h,10~14 h为生长平缓期,约16 h以后进入平台期,工程菌生长特性与减毒猪霍乱沙门菌C500的生长特性一致,未因携带质粒而改变。同时,各代菌液沙门菌种属标志基因invA和毒力基因crp的扩增条带大小均分别为580和599 bp,表明工程菌多次传代后仍具有沙门菌的特性,其减毒特性也无变化。各代质粒酶切片段大小均分别为498、1 146和2 622 bp,表明多次传代并不影响质粒的稳定性,且重组质粒能在沙门菌C500中维持正常拷贝功能。【结论】本研究构建的重组质粒和工程菌疫苗均具有良好的稳定性,且在导入机体后能正常表达,可用于动物免疫去势的研究。

关键词: 基因疫苗; 免疫去势; GnRH; KISS1; NKB

Abstract: 【Objective】 This experiment was aimed to construct different types of novel immune castration DNA vaccines, including KISS1, neurokinin B (NKB) single expression gene vaccines, and gonadotropin releasing hormone (GnRH), KISS1 and NKB three genes co-expression gene vaccines.After injection into animals, they could stimulate immune responses and produce corresponding antibodies, thereby achieving the goal of reducing androgens by regulating the reproductive axis.【Method】 By selecting GnRH and its upstream regulatory genes KISS1 and NKB on the hypothalamic pituitary gonadal axis as targets, and introducing a balanced lethal system instead of antibiotic screening, the recombinant plasmids was constructed.The three expression plasmids were co-expressed with the target gene through the self-cleavage function of the 2A peptide.After transfecting the recombinant plasmids into 293T cells, the cell RNA was extracted to verify its normal expression in the body.Subsequently, the successfully constructed plasmids were electrically transferred to attenuated Salmonella Choleraesuis C500 competent cells to obtain recombinant live bacterial vaccines.The constructed engineered bacteria were continuously passaged 50 times in vitro, and the stability studies were conducted on strains from the 0, 2nd, 5th, 10th, 20th, 30th, 40th and 50th generations.【Result】 Recombinant plasmids pVAX-2A/KISS1-asd, pVAX-2A/S-NKB-asd and pVAX-S/GnRH-2A/S-NKB-2A/KISS1-asd were digested to obtain bands of 498, 1 146 and 2 622 bp, respectively, consistent with the target gene.After comparing the sequencing results with the target sequence, it was found that the size and direction were consistent.The recombinant plasmids were transfected into 293T cells and subjected to RT-PCR to obtain target bands of 498, 1 146 and 1 349 bp, respectively, indicating that the target gene could be transcribed normally in eukaryotic cells.After the above recombinant plasmids were electrically transferred into attenuated Salmonella Choleraesuis C500 competent cells, the extracted plasmids were digested and the band sizes were 498, 1 146 and 2 622 bp, respectively.The sequencing results were consistent with the target sequence, indicating that the recombinant plasmids were successfully introduced into attenuated Salmonella Choleraesuis C500.The D600 nm values of recombinant engineering bacteria and attenuated Salmonella Choleraesuis C500 bacteria detected every 2 h were similar, and the difference was not significant.The growth curve test results showed that during the process of 50 consecutive passages in vitro, the logarithmic growth period of both engineering bacteria and attenuated Salmonella Choleraesuis C500 bacteria were around 0-10 h, with a growth plateau period of 10-14 h.After about 16 h, entering the platform phase, the growth characteristics of the engineering bacteria were consistent with those of the attenuated Salmonella Choleraesuis C500, and did not change due to carrying plasmids.At the same time, the amplified bands of the Salmonella genus marker gene invA and virulence gene crp in each generation of bacterial fluid were 580 and 599 bp, respectively.The results showed that the recombinant engineered bacteria still possessed the characteristics of Salmonella after multiple passages, and their detoxification characteristics remained unchanged.The results of plasmid digestion in each generation were 498, 1 146 and 2 622 bp, indicating that multiple passages did not affect the stability of the plasmid, and the recombinant plasmid was able to maintain normal copy function in Salmonella Choleraesuis C500.【Conclusion】 The constructed recombinant plasmids and engineered bacterial vaccines had good stability and could be expressed normally after being introduced into the body, making them suitable for research on animal immune castration.

Key words: gene vaccine; immune castration; GnRH; KISS1; NKB

中图分类号: